(Q71497698)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

In vitro assessment of various cytochromes P450 and glucuronosyltransferases using the antiarrhythmic propafenone as a probe drug (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

H K Kroemer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

S Botsch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

G Heinkele

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

M Schick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

published in

Methods in Enzymology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

99-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

Identification of propafenone metaboliser phenotype from plasma and urine excretion data.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

Rapid determination of CYP2D6 phenotype during propafenone therapy by analysing urinary excretion of propafenone glucuronides

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

Synthesis of the glucuronide of carazolol

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2972012-8

7 January 2021

10.1016/S0076-6879(96)72012-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8791766%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference